NIAID scientists consider 200 years of infectious diseases

February 2, 2012

Unpredictable, ever-changing and with potentially far-reaching effects on the fates of nations, infectious diseases are compelling actors in the drama of human history, note scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In an essay marking 200 years of publication of the New England Journal of Medicine, NIAID Director Anthony S. Fauci, M.D., and coauthor David M. Morens, M.D., trace key advances in understanding and combatting infectious diseases and outline ways in which the contest between microbes and man might play out in decades to come.

The authors look back to the 1799 death, likely from bacterial epiglottitis, of President George Washington and note that "no one alive then could have imagined the astonishing breakthroughs that lay ahead." Among these was the idea that identifiable microbes lead to specific illnesses, an insight that opened the way to more accurate diagnoses, a host of and and a tool—vaccination—to prevent many infections altogether. Combined, these interventions have saved hundreds of millions of lives and lessened the burden of human suffering, the authors note.


Laudable successes—such as the elimination of smallpox—are, however, balanced against the inevitable emergence of newer pathogens, such as HIV, that can sweep the globe and devastate societies, observe the authors. This tug-of-war between constantly evolving microbes and the human ingenuity required to address newly emerging illnesses makes for the perpetual challenge of . Efforts to address this challenge, they write, "are driven by the necessity of expecting the unexpected and being prepared to respond when the unexpected occurs."

Explore further: NIH scientists outline steps toward Epstein-Barr virus vaccine

More information: AS Fauci and DM Morens. The perpetual challenge of infectious diseases. New England Journal of Medicine DOI:10.1056/NEJMra1108296 (2012).

Related Stories

NIH scientists outline steps toward Epstein-Barr virus vaccine

November 2, 2011

Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood ...

Recommended for you

Kidney stone? Try a roller coaster ride

September 27, 2016

(HealthDay)—Anyone who's suffered a kidney stone just wants the urinary obstruction gone. Now, preliminary research suggests relief might even be fun: a roller coaster ride.

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.